U.S. Pledges Up to $2.1 Billion for Sanofi, GlaxoSmithKline Covid Vaccine
(Bloomberg) -- The Trump administration will provide as much as $2.1 billion to Covid-19 vaccine partners Sanofi and GlaxoSmithKline Plc, the biggest U.S. investment yet in fast-tracking shots and ...